- Home
- MPX vs LXRX Comparison
MPX vs LXRX Comparison
Compare MPX & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPX
- LXRX
- Stock Information
- Founded
- MPX 1965
- LXRX 1995
- Country
- MPX United States
- LXRX United States
- Employees
- MPX N/A
- LXRX N/A
- Industry
- MPX Marine Transportation
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- MPX Industrials
- LXRX Health Care
- Exchange
- MPX Nasdaq
- LXRX Nasdaq
- Market Cap
- MPX 332.6M
- LXRX 352.5M
- IPO Year
- MPX N/A
- LXRX 2000
- Fundamental
- Price
- MPX $9.33
- LXRX $0.71
- Analyst Decision
- MPX Hold
- LXRX Buy
- Analyst Count
- MPX 1
- LXRX 2
- Target Price
- MPX $8.00
- LXRX $6.00
- AVG Volume (30 Days)
- MPX 37.2K
- LXRX 5.4M
- Earning Date
- MPX 01-23-2025
- LXRX 11-12-2024
- Dividend Yield
- MPX 6.00%
- LXRX N/A
- EPS Growth
- MPX N/A
- LXRX N/A
- EPS
- MPX 0.53
- LXRX N/A
- Revenue
- MPX $259,608,000.00
- LXRX $5,229,000.00
- Revenue This Year
- MPX N/A
- LXRX $886.38
- Revenue Next Year
- MPX $5.00
- LXRX $181.58
- P/E Ratio
- MPX $17.62
- LXRX N/A
- Revenue Growth
- MPX N/A
- LXRX 886.60
- 52 Week Low
- MPX $8.86
- LXRX $0.62
- 52 Week High
- MPX $12.47
- LXRX $3.73
- Technical
- Relative Strength Index (RSI)
- MPX 40.88
- LXRX 36.95
- Support Level
- MPX $9.52
- LXRX $0.66
- Resistance Level
- MPX $9.67
- LXRX $0.85
- Average True Range (ATR)
- MPX 0.30
- LXRX 0.10
- MACD
- MPX -0.06
- LXRX 0.02
- Stochastic Oscillator
- MPX 20.00
- LXRX 23.67
About MPX Marine Products Corporation
Marine Products Corp is a manufacturer of fiberglass motorized boats distributed and marketed through its independent dealer network. The company's only operating segment is Powerboat Manufacturing Business. It operates in the Powerboat Manufacturing business segment through Nashville, Georgia, Valdosta, and Georgia. Its product offerings include Chaparral sterndrive, outboard pleasure boats and Robalo outboard sport fishing boats. The company offers its products to the family recreational markets through its Chaparral brand and to the sportfishing market through its Robalo brand.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.